LSD1 inhibitors and medical uses thereof
US10517849B2 · kind B2 · utility
2Cited by
14References
23Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 26, 2017 |
| Grant date | Dec 31, 2019 |
| Priority date | — |
| Expiry date | Oct 26, 2037 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D221/20
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided are novel compounds of Formula (I or Ia′): and pharmaceutically acceptable salts thereof, which are useful for treating a variety of diseases, disorders or conditions, associated with LSD1. Also provided are pharmaceutical compositions comprising the novel compounds of Formula (I or Ia′), pharmaceutically acceptable salts thereof, and methods for their use in treating one or more diseases, disorders or conditions, associated with LSD1.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.